erythromycin

erythromycin is a lipid of Polyketides (PK) class. Erythromycin is associated with abnormalities such as Systemic Inflammatory Response Syndrome, Pneumonia, Infection, Pneumococcal Infections and Exanthema. The involved functions are known as Pharmacodynamics, Sterility, Agent, Drug Kinetics and Adjudication. Erythromycin often locates in Blood, peritoneal, Extracellular, Ribosomes and apicoplast. The associated genes with erythromycin are P4HTM gene, SLC33A1 gene, FAM3B gene, Operon and Homologous Gene. The related lipids are Hydroxytestosterones, Steroids, Propionate, Mycolic Acids and campesterol. The related experimental models are Mouse Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of erythromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with erythromycin?

erythromycin is suspected in Pneumonia, Infection, Gonorrhea, Cystic Fibrosis, Respiratory Tract Infections, Influenza and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with erythromycin

MeSH term MeSH ID Detail
Synovitis D013585 15 associated lipids
Tremor D014202 15 associated lipids
Staphylococcal Infections D013203 15 associated lipids
Bronchial Hyperreactivity D016535 15 associated lipids
Uveitis D014605 14 associated lipids
Stomatitis D013280 14 associated lipids
Hypersensitivity, Immediate D006969 14 associated lipids
Abscess D000038 13 associated lipids
Multiple Myeloma D009101 13 associated lipids
Rosacea D012393 13 associated lipids
Mycoplasma Infections D009175 13 associated lipids
Campylobacter Infections D002169 13 associated lipids
Bradycardia D001919 13 associated lipids
Pain, Postoperative D010149 13 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Airway Obstruction D000402 13 associated lipids
Urticaria D014581 13 associated lipids
Critical Illness D016638 13 associated lipids
Hematuria D006417 13 associated lipids
Corneal Diseases D003316 13 associated lipids
Per page 10 20 50 100 | Total 442

PubChem Associated disorders and diseases

What pathways are associated with erythromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with erythromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with erythromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with erythromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with erythromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with erythromycin?

Mouse Model

Mouse Model are used in the study 'In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis.' (Falzari K et al., 2005) and Mouse Model are used in the study 'Activity of ABT-773 against Mycobacterium avium complex in the beige mouse model.' (Cynamon MH et al., 2000).

Knock-out

Knock-out are used in the study 'Functional expression and comparative characterization of nine murine cytochromes P450 by fluorescent inhibition screening.' (McLaughlin LA et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with erythromycin

Download all related citations
Per page 10 20 50 100 | Total 13660
Authors Title Published Journal PubMed Link
Lauenstein TC et al. Time-resolved three-dimensional MR imaging of gastric emptying modified by IV administration of erythromycin. 2003 AJR Am J Roentgenol pmid:12704042
Simakova MG et al. [Clinical aspects, diagnosis and treatment of intrauterine infections]. 1995 Akush Ginekol (Mosk) pmid:7485765
Mezinova NN et al. [Effect of anti-chlamydial drugs on the effectiveness of the treatment of habitual abortion]. 1991 Akush Ginekol (Mosk) pmid:1951968
Mezinova NN and Chuchupalov PD [Endometrial Chlamydia infection in women with habitual abortion]. 1992 Akush Ginekol (Mosk) pmid:1476220
Kotua EN and Moroz AF [Erythromycin-ascorbinate therapy of pregnant rats with staphylococcal infections caused by staphylococcal strains both sensitive and resistant to erythromycin]. 1971 Akush Ginekol (Mosk) pmid:5138198
Kotua EN and Moroz AF [Passage of erythromycin and ristomycin into blood, placenta, fetus and amniotic fluid during various stages of pregnancy in generalized staphylococcal infection in albino rats]. 1971 Akush Ginekol (Mosk) pmid:4328638
Thornton JB and Harris JH The prevention of bacterial endocarditis. A new approach to a changing disease. 1986 Ala J Med Sci pmid:3953983
BOURICHON J [Importance of the suppository form in the administration of propionyl-erythromycin to children]. 1962 Alger Medicale pmid:13871918
LEBON J et al. [Staphylococcal diarrhea after terramycin administration; cure by erythromycin]. 1955 Alger Medicale pmid:14398597
Verhagen MA et al. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers. 1997 Aliment. Pharmacol. Ther. pmid:9663833
Talley NJ et al. Failure of a motilin receptor agonist (ABT-229) to relieve the symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. 2000 Aliment. Pharmacol. Ther. pmid:11121915
Emmanuel AV et al. Erythromycin for the treatment of chronic intestinal pseudo-obstruction: description of six cases with a positive response. 2004 Aliment. Pharmacol. Ther. pmid:15023171
Athanasakis E et al. Octreotide enhances the accelerating effect of erythromycin on gastric emptying in healthy subjects. 2002 Aliment. Pharmacol. Ther. pmid:12182757
Bell GD et al. Short report: omeprazole plus antibiotic combinations for the eradication of metronidazole-resistant Helicobacter pylori. 1992 Aliment. Pharmacol. Ther. pmid:1486161
van Erpecum KJ et al. Review article: agents affecting gall-bladder motility--role in treatment and prevention of gallstones. 2000 Aliment. Pharmacol. Ther. pmid:10903008
Minocha A et al. Erythromycin shortens orocaecal transit time in diabetic male subjects: a double-blind placebo-controlled study. 1995 Aliment. Pharmacol. Ther. pmid:8580273
Jameson JS et al. Oral or intravenous erythromycin has no effect on human distal colonic motility. 1992 Aliment. Pharmacol. Ther. pmid:1420750
Osato MS et al. Comparative efficacy of new investigational agents against Helicobacter pylori. 2001 Aliment. Pharmacol. Ther. pmid:11284777
Laine L et al. Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori. 1996 Aliment. Pharmacol. Ther. pmid:8791949
Wehrmann T et al. Effect of erythromycin on human biliary motility. 1996 Aliment. Pharmacol. Ther. pmid:8791972